Now Enrolling: Canine Osteosarcoma Clinical Trial

ELIAS Animal Health is currently conducting an osteosarcoma clinical trial to evaluate its ELIAS Cancer Immunotherapy (ECI®)—a vaccine-enhanced adoptive cell therapy—combined with surgery as a treatment for cancer in dogs. ELIAS has developed a unique immunotherapy treatment protocol which may permit the dog’s immune system to attack its own cancer cells. ECI has demonstrated effectiveness in clinical trials in both canines and humans, while avoiding or minimizing the need for chemotherapy or radiation treatment.

ELIAS is providing financial assistance that will substantially cover costs of participation and treatment in the trial.

Trial Summary

  • Trial enrollment is required prior to amputation (affected limb must be intact)
  • Treatment includes either ECI immunotherapy or carboplatin chemotherapy
  • Patients must complete a 7-11 week treatment regimen and return for quarterly follow-up visits throughout the 18-month trial
  • Study sponsor will cover treatment costs (including consult with oncologist, radiographs, lab work, ECI immunotherapy or carboplatin chemotherapy treatment, and their administration)

Inclusion Criteria

Patients may be eligible for this study if they meet the following criteria:

  • Appendicular osteosarcoma with the limb still in place
  • Patient determined to be in sufficiently good health overall to undergo and complete the treatment schedule
  • Is not currently pregnant or lactating
  • Has not previously received any treatments for its cancer
  • Does not have metastatic disease (tumor spread) at the time of diagnosis
  • Is not currently on immunosuppressive drugs
  • Is not currently taking any supplements, herbal products, or other natural remedies for its cancer or other health related issues
  • Does not have a second malignancy
  • Must weigh at least 15 kg
  • Owner/guardian is willing and able to take the dog to all scheduled clinic visits during the treatment schedule, as well as the follow up visits

To learn more about this therapy and to see if your dog or canine patient may be a good candidate, please schedule a visit with a participating hospital near you.

Participating Hospitals

Veterinary Cancer Group – Pathways
Tustin, CA
Phone: (949) 552-8274

Aspen Meadow Veterinary Specialists
Longmont, CO
Phone: (303) 678–8844

Veterinary Specialty Center
Buffalo Grove, IL
Phone: (847) 459-7535

Kansas State University College of Veterinary Medicine
Manhattan, KS
Phone: (785) 532-5690

North Carolina State University
Raleigh, NC
Phone: (919) 513-6786

Hope Veterinary Specialists
Malvern, PA
Phone: (610) 296-2099

Veterinary Oncology Services and Research Center
West Chester, PA
Phone: (610) 692-6272

VCA Animal Diagnostic Clinic
Dallas, TX
Phone: (972) 267-8300

VCA SouthPaws Veterinary Specialists
Fairfax, VA
Phone: (703) 752-9100

Friendship Hospital for Animals
Washington, D.C.
Phone (202) 363-7300